Accepted for Publication: February 7, 2014.
Published Online: July 23, 2014. doi:10.1001/jamadermatol.2014.251.
Study concept and design: Haeberle.
Acquisition, analysis, or interpretation of data: Todd, Callen, Bahrami.
Drafting of the manuscript: Haeberle, Todd.
Critical revision of the manuscript for important intellectual content: Haeberle, Callen, Bahrami.
Administrative, technical, or material support: Callen.
Study supervision: Callen, Bahrami.
Conflict of Interest Disclosures: Dr Callen reported receiving an honorarium for consulting for GlaxoSmithKline and serving on a safety monitoring committee for Celgene. Dr Callen is the associate editor of JAMA Dermatology. He was not involved in the editorial evaluation or decision to accept this article for publication. No other disclosures were reported.